This week, I ran across a piece on Specialty pharmacy exhorting “The time is now and here’s how!” in a (gulp) chain drug store publication. It is ten years old—and pharmacies are still working out how to do it, do it well, and do it profitably. It’s important because spending on Specialty drugs is a huge proportion of overall drug spend and is rising, according to QuintilesIMS, formerly IMS Health.
The DEA this week filed a notice of intent to place furanyl fentanyl into Schedule 1 saying that it is “necessary to avoid an imminent hazard to public safety.” Forbes reports the substance has been cited in 128 deaths over the past year, just another in a long list of tragedies associated with the opioid crisis. Which is why this investigation in naloxone price hikes-a-la-EpiPen is so unnerving—and a good listen.
Here are few stories we came across this week that you might find interesting: